Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: Prognostic value of the length of venous resection

Surgery

Volumn 145, Issue 4, 2009, Pages 417-425

  Kaneoka, Yuji ^a   Yamaguchi, Akihiro ^a   Isogai, Masatoshi ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILIAC VEIN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PORTAL VEIN RESECTION; PRIORITY JOURNAL; PROGNOSIS; SUPERIOR MESENTERIC VEIN RESECTION; VEIN GRAFT; VEIN SURGERY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MESENTERIC VEINS; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PORTAL VEIN; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 62349110974     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.12.009     Document Type: Article

References (27)

1. Pedrazzoli S., DiCarlo V., Dionigi R., Mosca F., Pederzoli P., Pasquali C., et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas. A multicenter, prospective, randomized study. Ann Surg 228 (1998) 508-517
2. Yeo C.J., Cameron J.L., Sohn T.A., Coleman J., Sauter P.K., Hruban R.H., et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229 (1999) 613-624
3. Yeo C.J., Cameron J.L., Lillemoe K.D., Sohn T.A., Campbell K.A., Sauter P.K., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2. Randomized controlled trial evaluating survival, morbidity, mortality. Ann Surg 236 (2002) 355-368
4. Farnell M.B., Pearson R.K., Sarr M.G., DiMagno E.P., Burgart L.J., Dahl T.R., et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138 (2005) 618-630
5. Leach S.D., Lee J.E., Charnsangavej C., Cleary K.R., Lowy A.M., Fenoglio C.J., et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 85 (1998) 611-617
6. Fuhrman G.M., Leach S.D., Staley C.A., Cusack J.C., Charnsangavej C., Cleary K.R., et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Ann Surg 223 (1996) 154-162
7. Harrison L.E., Klimstra D.S., and Brennan M.F. Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection. Ann Surg 224 (1996) 342-349
8. Bachellier P., Nakano H., Oussoultzoglou E., Weber J.C., Boudjema K., Wolf P., et al. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?. Am J Surg 182 (2001) 120-129
9. Carrere N., Sauvanet A., Goera D., Kianmanesh R., Vullierme M.P., Couvelard A., et al. Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head. World J Surg 30 (2006) 1526-1535
10. Riediger H., Makowiec F., Adam E.V.U., and Hopt U.T. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg 10 (2006) 1106-1115
11. Sobin H.L., and Wiitekind C. TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss, New York
12. Fortner J.G. Regional resection of cancer of the pancreas: a new surgical approach. Surgery 73 (1973) 307-320
13. van Geenen R.C., ten Kate F.J., de Wit L.T., van Gulik T.M., Obertop H., and Gouma D.J. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 129 (2001) 158-163
14. Yekebas E.F., Bogoevski D., Cataldegirmen G., Kunze C., Marx A., Vashist Y.K., et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels. Perioperative outcome and long-term survival in 136 patients. Ann Surg 247 (2008) 300-309
15. Nakao A., Harada A., Nonami T., Kaneko T., Inoue S., and Takagi H. Clinical significance of portal invasion by pancreatic head carcinoma. Surgery 117 (1995) 50-55
16. Nakao A., Takeda S., Inoue S., Nomoto S., Kanazumi N., Sugimoto H., et al. Indications and techniques of extended resection for pancreatic cancer. World J Surg 30 (2006) 976-982
17. Varadhachary G.R., Tamm E.P., Abbruzzese J.L., Xiong H.Q., Crane C.H., Wang H., et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13 (2006) 1035-1046
18. Boa P.Q., Johnson J.C., Lindsey E.H., Schwartz D.A., Arildsen R.C., Grzeszczak E., et al. Endoscopic ultrasound and computed tomography predicts of pancreatic cancer respectability. J Gastrointest Surg 12 (2008) 10-16
19. Siriwardana H.P.P., and Siriwardena A.K. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 93 (2006) 662-673
20. Klempnauer J., Ridder G.J., Bektas H., and Pichlmayr R. Extended resections of ductal pancreatic cancer-impact on operative risk and prognosis. Oncology 53 (1996) 47-53
21. Wagner M., Redaelli C., Lietz M., Seiler C.A., Friess H., and Buchler M.W. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91 (2004) 586-594
22. Ishikawa O., Ohigashi H., Imaoka S., Furukawa H., Sasaki Y., Fujita M., et al. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 215 (1992) 231-236
23. National Comprehensive Cancer Network (NCCN). Practice Guidelines for Pancreatic Cancer. Available at: http://www.nccn.org.
24. Breslin T.M., Hess K.R., Harbison D.B., Jean M.E., Cleary K.R., Dackiw A.P., et al. Neoadjuvant chemoradiation therapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8 (2001) 123-132
25. Oettle H., Post S., Neuhaus P., Gellert K., Langrehr J., Ridwelski K., et al. Adjuvant chemotherapy with gemecitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297 (2007) 267-277
26. Tseng J.F., Raut C.P., Lee J.E., Pisters P.W.T., Vautbey J.N., Abdalla E.K., et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8 (2004) 935-950
27. Koniaris L.G., Staveley-O'Carrol K.F., Zeh H.J., Perez E., Jin X., Maley W.R., et al. Pancreaticoduodenectomy in the presence of superior mesenteric venous obstruction. J Gastrointest Surg 9 (2005) 915-921